ClinicalTrials.govpublic full text
Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
lymphoma, follicular lymphoma, immunotherapy, ct-011, monoclonal antibody ct-011, rituximab, rituxan, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803524
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.